Covered recipient · General Payments record
DUREYA SYED
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2024
$212.01
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $212.01 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $117.38 | 5 |
| Relypsa, Inc. | $25.60 | 1 |
| Ardelyx, Inc. | $25.57 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $23.48 | 1 |
| Aurinia Pharma U.S., Inc. | $19.98 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $212.01 | 9 |
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ardelyx, Inc. | $25.57 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146710245 | CMS |
| AstraZeneca Pharmaceuticals LP | $30.16 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105513733 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.03 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104672971 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.71 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104430875 | CMS |
| AstraZeneca Pharmaceuticals LP | $26.34 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104213545 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.14 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105438382 | CMS |
| Aurinia Pharma U.S., Inc. | $19.98 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150693093 | CMS |
| Novartis Pharmaceuticals Corporation | $23.48 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087340565 | CMS |
| Vifor Pharma, Inc. | $25.60 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124067427 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.